For example, miR-216b inhibited the proliferation and invasion of non-small cell lung cancer (NSCLC) cells by directly targeting SOX9, and miR-145 reduced the adhesion and invasion of glioblastoma cells by inhibiting the carcinogenic proteins of SOX9 and ADD3 [35, 36]. Here, ADD3 is linked to non-small cell lung carcinoma.